Pharmacokinetics and intramuscular bioavailability of difloxacin in dromedary camels (Camelus dromedarius)

Veterinary Journal

Volumn 179, Issue 2, 2009, Pages 282-286

  Abo El Sooud, K ^a   Goudah, A ^a  

^a Cairo University   (Egypt)

Author keywords

Bioavailability; Camels; Difloxacin; High performance liquid chromatography; Pharmacokinetics

Indexed keywords

DICURAL; DIFLOXACIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL INFECTION; CAMEL; COMPARTMENT MODEL; CONTROLLED STUDY; DISTRIBUTION VOLUME; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG PROTEIN BINDING; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; SINGLE DRUG DOSE;

ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CAMELS; CIPROFLOXACIN; INJECTIONS, INTRAMUSCULAR; INTESTINAL ABSORPTION; MALE;

BACTERIA (MICROORGANISMS); CAMELIDAE; CAMELUS DROMEDARIUS;

EID: 58249106174     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2008.05.011     Document Type: Article

References (34)

1. Abd El-Aty A.M., Goudah A., Ismail M., and Shimoda M. Disposition kinetics of difloxacin in rabbit after intravenous and intramuscular injection of dicural. Veterinary Research Communications 29 (2005) 297-304
2. Abd El-Aty A.M., Goudah A., Shah S.S., Shin H.C., Shimoda M., and Shim J.H. Pharmacokinetic variables of moxifloxacin in healthy male camels following intravenous and intramuscular administration. Journal of Veterinary Pharmacology and Therapeutics 30 (2007) 586-591
3. Al Katheeri N.A., Wasfi I.A., Lambert M., Giuliano Albo A., and Nebbia C. Invivo and in vitro metabolism of dexamethasone in the camel. The Veterinary Journal 172 (2006) 532-543
4. Ali B.H., and Hassan T. Some observations on the toxicosis of isometamidium chloride (Samorin) in camels. Veterinary and Human Toxicology 28 (1986) 424-426
5. Aliabadi F.S., Ali B.H., Landoni M.F., and Lees P. Pharmacokinetics and PK-PD modeling of danofloxacin in camel serum and tissue cage fluids. The Veterinary Journal 165 (2003) 104-118
6. Atef M., El-Banna H.A., Abd El-Aty A.M., and Goudah A. Pharmacokinetics of difloxacin in goats. Deutsche Tierarztliche Wochenschrift 109 (2002) 320-323
7. Barre J., Houin G., and Tillement J.P. Dose-dependent pharmacokinetic study of pefloxacin, a new antibacterial agent in humans. Journal of Pharmaceutical Science 73 (1984) 1379-1382
8. Carceles C.M., Villamayor L., Escudero E., Marin P., and Fernandez-Varon E. Pharmacokinetics and milk penetration of moxifloxacin after intramuscular administration to lactating goats. The Veterinary Journal 173 (2007) 452-455
9. Craig W.A. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clinical Infectious Diseases 26 (1998) 1-10
10. Craig A.W., and Suh B. Protein binding and the antibacterial effects. Method for the determination of protein binding. In: Lorian V. (Ed). Antibiotics in Laboratory Medicine (1991), Williams and Wilkins, Baltimore, MD 367-402
11. Drlica K., and Zhao X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiology and Molecular Biology Reviews 61 (1997) 377-392
12. Fernandez-Varon E., Cárceles C.M., Mari{dotless}́n P., Martos N., Escudero E., and Ayala I. Pharmacokinetics of difloxacin after intravenous, intramuscular and intragastric administration to horses. American Journal of Veterinary Research 67 (2006) 1076-1081
13. Frazier D.L., Thompson L., Terettien A., and Evans E.I. Comparison of fluoroquinolone pharmacokinetic parameters after treatment with marbofloxacin, enrofloxacin and difloxacin in dogs. Journal of Veterinary Pharmacology and Therapeutics 23 (2000) 293-302
14. Granneman G.R., Synder K.M., and Shu V.S. Difloxacin metabolism and pharmacokinetics in human after oral doses. Antimicrobial Agents and Chemotherapy 30 (1986) 689-693
15. Gibaldi M., and Perrier D. Non compartmental analysis based on statistical moment theory. second ed. Pharmacokinetics (1982), Marcel Dekker, New York pp. 409-424
16. Goudah A. Disposition kinetics of moxifloxacin in lactating ewes. The Veterinary Journal 178 2 (2007) 282-287
17. Haddad N.S., Pedersoli W.M., Ravis W.R., Fazeli M.H., and Carson R.L. Combined pharmacokinetics of gentamicin in pony mares after a single IV and IM administration. American Journal of Veterinary Research 46 (1985) 2004-2007
18. Ismail M. Disposition kinetics of difloxacin after intravenous, intramuscular and subcutaneous administration in calves. Veterinary Research Communications 31 (2007) 467-476
19. Kadir A., Ali B.H., Alhadrami G., Bashir A.K., Landoni M.F., and Lees P. Phenylbutazone pharmacokinetics and bioavailability in the dromedary camel (Camelus dromedarius). Journal of Veterinary Pharmacology and Therapeutics 20 (1997) 54-60
20. Laraje R., Talmi A., Bounaga R., Bengoumi M., El Hraiki A., and Laurentie M. Comparative pharmacokinetics of marbofloxacin after a single intramuscular administration at two dosages to camels (Camelus dromedarius). Journal of Veterinary Pharmacology and Therapeutics 29 (2006) 229-231
21. Lode H., Borner K., and Koeppe P. Pharmacodynamics of fluoroquinolones. Clinical Infectious Disease 27 (1998) 33-39
22. Marin P., Fernandez-Varon E., Escudero E., and Carceles C.M. Pharmacokinetics after intravenous, intramuscular and subcutaneous administration of difloxacin in sheep. Research in Veterinary Science 83 (2007) 234-238
23. Olchowy T.W.J., TerHune T.N., and Herrick R.L. Efficacy of difloxacin in calves experimentally infected with Mannheimia haemolytica. American Journal of Veterinary Research 61 (2000) 710-713
24. Oukessou M. Kinetic disposition of flunixin meglumine in the camel. Veterinary Research 25 (1994) 71-75
25. Oukessou M., Berrag B., and Alvinerie M. A comparative kinetic study of ivermectin and moxidectin in lactating camels (Camelus dromedarius). Veterinary Parasitology 83 (1999) 151-159
26. Powers J. Statistical analysis of pharmacokinetics data. Journal of Veterinary Pharmacology and Therapeutics 13 (1990) 113-120
27. Siefert H.M., Domdey-Bette A., Henninger K., Hucke F., Kohlsdorfer C., and Stass H.H. Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: a comparison in humans and other mammalian species. The Journal of Antimicrobial Chemotherapy 43 Suppl. B (1999) 69-76
28. Stamm J.M., Hanson C.W., Chu D.T.W., Bailer R., and Vojtko C. In vitro evaluation of A-56619 (Difloxacin) A-56620: new aryl-fluoroquinolones. Antimicrobial Agents and Chemotherapy 29 (1986) 193-200
29. Toutain P.L., and Bousquet-Melou A. Volumes of distribution. Journal of Veterinary Pharmacology and Therapeutics 27 (2004) 441-453
30. Turnidge J. Pharmacokinetics and pharmacodynamics of fluoroquinolones. Drugs 58 (1999) 29-36
31. Walker R.D. Fluoroquinolones. In: Prescott J.F., Baggot J.D., and Walker R.D. (Eds). Antimicrobial Therapy in Veterinary Medicine. third ed. (2000), Iowa State University Press, Ames, USA 315-338
32. Wilson, R.T., 1984. The Camel. Longman Group Limited Longman House, Essex, pp. 69-77.
33. Yagil R. The Desert Camel. Comparative Physiological Adaptation (1985), Karger Limited, Basel pp. 19-42
34. Yamaoka K., Nakagawa T., and Uno T. Statistical moment in pharmacokinetics. Journal of Pharmacokinetic and Biopharmaceutics 6 (1978) 547-558